VanEck's NLR nuclear-focused ETF offers higher dividend yield (3.1%) but underperformed significantly with a 21.8% loss over the past year, while iShares' ICLN renewable energy ETF gained 11.0% with lower costs (0.38% expense ratio). The choice between them depends on investor priorities: NLR provides concentrated nuclear exposure but faces regulatory and interest rate risks, while ICLN offers broader diversification across 105 holdings in solar, wind, and clean energy equipment.

Cameco (CCJ) declined 5.43% in recent trading, underperforming the S&P 500. The uranium producer is expected to report Q3 2026 earnings on October 30 with forecasted EPS of $0.23 (up 360% YoY) and revenue of $494.94 million (up 10.91% YoY). However, the stock carries a Zacks Rank #3 (Hold) rating with a Forward P/E of 80.77, significantly above the industry average of 17.7, suggesting premium valuation despite positive earnings growth expectations.

BWX Technologies (BWXT) is expanding its nuclear materials processing capabilities through uranium recovery, purification, and downblending activities. The company's Uranium Processing and Nuclear Services segment revenues grew significantly to $406.6 million in 2025 from $287 million in 2024, with $68.1 million attributed to higher uranium processing and downblending activity. BWXT trades at a discount to industry peers with a forward P/S ratio of 3.23X versus 6.89X industry average, though shares have declined 23.6% over three months. The company holds a Zacks Rank #3 (Hold) with projected EPS growth of 18.45% in 2026 and 10.10% in 2027.

Amazon and Alphabet have signed 20-year nuclear power purchase agreements with Constellation Energy, signaling the tech industry's commitment to nuclear energy for AI data centers. While Constellation is well-positioned as a major nuclear generator, Cameco—which supplies uranium and owns 49% of Westinghouse—is highlighted as a better investment opportunity, trading 35% below analyst targets as nuclear capacity is expected to triple by 2050.

Cameco (CCJ) stock declined 4.25% on October 7, 2026, underperforming the broader market. Despite strong earnings growth projections (360% EPS increase YoY), the stock has dropped 8.78% over the past month and carries a Zacks Rank #5 (Strong Sell) rating. The company trades at a premium valuation with a Forward P/E of 86.8 versus the industry average of 17.95, and recent analyst estimates have been revised downward by 4.17%.

The Department of Energy announced a $4.2 billion loan commitment to Vistra to extend and upgrade three nuclear plants in Pennsylvania and Ohio, preserving 4 GW of power and adding 433 MW of new capacity. This deal is part of Trump's broader initiative to quadruple U.S. nuclear capacity to 400 GW by 2050. Meta has already signed a 20-year power purchase agreement with Vistra for 2,609 MW from these plants, highlighting how existing reactor owners are positioned to benefit most from the nuclear renaissance driven by AI energy demands.

Three companies have been added to the Zacks Rank #5 (Strong Sell) list today due to downward revisions in earnings estimates. AB Volvo faces a 2.3% downward earnings revision, Accendra Health has experienced a significant 109.4% downward revision, and Cameco Corporation saw a 12.2% downward revision over the last 60 days.

Energy Fuels (UUUU) trades at a significant valuation premium despite a 39.8% stock decline over six months and Q2 losses. While the company shows strong long-term growth potential through uranium production expansion and rare earth element operations, it remains unprofitable with downward earnings estimate revisions. Analysts recommend investors wait for more consistent earnings improvement before investing.

Cameco's stock has fallen below $90 from a 52-week high of $135.24, presenting a potentially cheaper entry point for investors. While recent operational challenges and lower Q2 earnings have pressured the stock, the company's long-term uranium supply contracts, 49% stake in Westinghouse, and exposure to growing nuclear demand remain strategically sound. The pullback improves valuation for those bullish on nuclear expansion, though the stock still commands a premium.

Cameco's stock has fallen from $134 to $85 after initial investor enthusiasm for nuclear power waned. However, the article argues this presents an opportunity, as nuclear power is experiencing a genuine renaissance driven by surging electricity demand from AI and electric vehicles. With uranium supply expected to fall short of demand in the early 2030s and Cameco owning half of Westinghouse, the company is well-positioned to benefit from the nuclear comeback.

Cameco, North America's largest uranium miner, delivered a 26% annual return over the past decade. Despite being down 5% this year, analysts project mid-to-high double-digit growth over the next five years driven by long-term uranium contracts, data center nuclear power demand, and potential gains from Westinghouse's upcoming IPO, which could value Cameco's 49% stake at approximately $24.5 billion.

Cameco (CCJ) closed down 1.13% and has underperformed the S&P 500 over the past month, losing 10.08%. While the company is expected to post strong EPS growth of 420% and modest revenue growth of 10.91% in the upcoming quarter, analyst estimates have been revised downward by 3.89% in the past 30 days. The stock carries a Zacks Rank #4 (Sell) rating and trades at a premium valuation with a Forward P/E of 75.26 compared to its industry average of 16.98.